Evolent Health Inc
NYSE:EVH

Watchlist Manager
Evolent Health Inc Logo
Evolent Health Inc
NYSE:EVH
Watchlist
Price: 4.17 USD 0.24% Market Closed
Market Cap: 465.4m USD

Net Margin
Evolent Health Inc

-8.8%
Current
-5%
Average
1.9%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-8.8%
=
Net Income
-180.9m
/
Revenue
2.1B

Net Margin Across Competitors

No Stocks Found

Evolent Health Inc
Glance View

Evolent Health Inc. emerged in 2011 from a collaboration between The Advisory Board Company and the University of Pittsburgh Medical Center, with a mission to reshape healthcare delivery in the United States. As the healthcare landscape shifted towards value-based care models, where providers are compensated for keeping patients healthy rather than on the volume of services delivered, Evolent positioned itself as a pivotal partner for healthcare systems aiming to transition smoothly into this new paradigm. The company's core offerings revolve around its technology-driven platform, which integrates data analytics, care management, and clinical expertise to enable healthcare providers and payers to deliver more efficient and patient-centric care. By providing these services, Evolent helps its clients reduce costs and improve patient outcomes, thus thriving in a rapidly evolving industry. From a business perspective, Evolent Health generates revenue primarily through two streams: provider services and performance-based contracts. For its provider services, Evolent signs agreements with healthcare providers, offering them proprietary technology and consulting services, all designed to enhance their operational efficiency and clinical capabilities. The performance-based contracts, which are fundamental in a value-based care environment, allow Evolent to share in the financial benefits realized by its clients from improved patient care and cost savings. This model not only aligns Evolent's success with that of its clients but also positions the company at the heart of the healthcare value chain, asserting its influence through partnerships that are financially symbiotic.

EVH Intrinsic Value
19.13 USD
Undervaluation 78%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-8.8%
=
Net Income
-180.9m
/
Revenue
2.1B
What is the Net Margin of Evolent Health Inc?

Based on Evolent Health Inc's most recent financial statements, the company has Net Margin of -8.8%.

Back to Top